STAAR Surgical Company (STAA) News
Filter STAA News Items
STAA News Results
|Loading, please wait...|
Latest STAA News From Around the Web
Below are the latest news stories about Staar Surgical Co that investors may wish to consider to help them evaluate STAA as an investment opportunity.
Staar Surgical (STAA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
In the daily bar chart of STAA, below, we can see that the shares have tripled over the past 12 months. The On-Balance-Volume (OBV) is positive but shows a small dip in July suggesting some profit-taking. In this weekly Japanese candlestick chart of STAA, below, we can see the past three years of price history.
Companies like Amazon or Visa that can generate double-digit compound growth in revenue and earnings, year after year, are rarities. These smaller candidates could do just that.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
In latest buying and selling, shares of Staar Surgical Co. (Image: STAA) have crossed above the common analyst 12-month goal value of $150.00, altering palms for $155.05/share. When a inventory reaches the goal an analyst has set, the analyst logically has two methods to react: downgrade on valuation, or, re-adjust their goal value to a  The post STAA Crosses Above Common Analyst Goal appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .
Staar Surgical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Thank you for joining us on the STAAR Surgical conference call this afternoon to discuss the company's financial results for the second quarter ended July 2, 2021. On the call today are Caren Mason, President and Chief Executive Officer; and Patrick Williams, Chief Financial Officer.
STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended July 2, 2021. Second Quarter 2021 Overview Record Quarterly Net Sales of $62.4 Million Up 77% from the Prior Year Quarter Record Quarterly ICL Sales of $59.2 Million Up 93% from the Prior Year Quarter Record Quarterly ICL Units, Up 79% from the Pr
Staar Surgical (STAA) delivered earnings and revenue surprises of 237.50% and 17.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.